-transparent.png){kind=logo}
The in-vitro activities of trospectomycin, cefpodoxime, cefamandole, cefonicid, and cefuroxime against beta-lactamase-negative and -positive invasive clinical isolates of Haemophilus influenzae type b were determined by the agar dilution method. Trospectomycin and cefpodoxime inhibited 90% of the strains at concentrations of 5 and 0.06 mg/l, respectively, and no differences between the susceptibilities of the beta-lactamase-negative and -positive strains were noted. The activity of cefpodoxime was minimally affected by increased inoculum size, but significant inoculum effects were noted with cefamandole, cefonicid, and cefuroxime with beta-lactamase positive strains.
Related Publications
J J LiPuma, and
B Daley, and
T L Stull
January 1988,
Infection,
J J LiPuma, and
B Daley, and
T L Stull
February 1995,
Australian journal of public health,
J J LiPuma, and
B Daley, and
T L Stull
September 1992,
Communicable disease report. CDR weekly,
J J LiPuma, and
B Daley, and
T L Stull
May 1986,
Lancet (London, England),
J J LiPuma, and
B Daley, and
T L Stull
March 1990,
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
J J LiPuma, and
B Daley, and
T L Stull
January 2006,
Methods in enzymology,
J J LiPuma, and
B Daley, and
T L Stull
June 1990,
Pediatric clinics of North America,
J J LiPuma, and
B Daley, and
T L Stull
November 1987,
The New England journal of medicine,
J J LiPuma, and
B Daley, and
T L Stull
June 1995,
Atencion primaria,
J J LiPuma, and
B Daley, and
T L Stull
January 1994,
Przeglad epidemiologiczny,
